Pricing Log in Create free account

Geron Corporation (GERN) vs Obsidian Therapeutics, Inc (OBX)

Geron Corporation and Obsidian Therapeutics, Inc are both Biotechnology companies. Geron Corporation and Obsidian Therapeutics, Inc are of similar size ($610.4M and $593.0M). Across the 6 metrics below, Obsidian Therapeutics, Inc leads on 4 and Geron Corporation on 2.

Valuation

Metric GERN OBX Biotechnology median
P/E n/m — 10.60
P/S 3.03 n/m 9.40
P/B 2.91 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.59 n/m 9.02
Earnings yield (7.49%) — (32.88%)
Free cash flow yield (13.84%) 0.00% (23.13%)

Profitability

Metric GERN OBX Biotechnology median
Gross margin 91.59% — 68.51%
Operating margin (14.75%) — 0.00%
Net margin (21.99%) — 0.00%
Free cash flow margin (41.91%) — 0.00%
Return on equity (20.12%) — (51.96%)
Return on assets (8.74%) — (46.06%)
Return on invested capital (34.12%) 0.00% 0.00%

Growth

Metric GERN OBX Biotechnology median
Revenue growth (TTM) 18.60% — 6.76%
EPS growth (last fiscal year) 51.85% (11.60%) 29.88%
Revenue growth, 5-year CAGR 273.49% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric GERN OBX Biotechnology median
Debt to equity 0.53 0.00 0.00
Current ratio 6.31 4.21 4.97
Net debt to EBITDA 3.28 0.77 1.01

Dividend

Metric GERN OBX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GERN OBX Biotechnology median
Market cap 610.41m 593.02m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack